AEON Biopharma (AEON) executive compensation, 2025 proxy

Marc Forth, Former President and Chief Executive Officer, was paid $5M in 2024, up 27% from $4M the year before.

Filed
December 29, 2025
Annual meeting
January 21, 2026
Pay year
2024
Named executives
3
CEO total pay
$5M+27% vs prior year
CEO pay in equity
89%$4.5M in awards
CEO Target Bonus
100%Of annual base salary
CMO Target Bonus
40%Of annual base salary
CLO Target Bonus
40%Of annual base salary
CEO 2024 Salary
$550,000Unchanged from prior year

How Forth was paid

$5M in total for 2024, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary11%Stock awards8%Option awards81%

Named executive officers

ExecutiveTotal
Marc ForthFormer President and Chief Executive Officer$5,044,599
Chad OhChief Medical Officer$2,302,013
Alex WilsonChief Legal Officer$2,143,856

What changed and why

  • $5MFormer CEO Marc Forth received total compensation of $5,044,599 in 2024, an increase from $3,982,378 in 2023.
  • Marc Forth received no annual bonus for 2024 due to his resignation effective April 4, 2025.
  • $42,500Chad Oh received a 2024 bonus of $42,500 and total compensation of $2,302,013.
  • $24,000Alex Wilson received a 2024 bonus of $24,000 and total compensation of $2,143,856.
  • Option awards formed the largest component of executive compensation for named executive officers in 2024.

Other AEON Biopharma proxy statements

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.